October 25th-26th, 2007
Location: Morristown, New Jersey
About one and a half billion people suffer from moderate to severe chronic pain worldwide and approximately 50 million Americans suffer with pain. The value of the pharmaceutical market for pain relief reflects this seeming worldwide epidemic of pain, with the overall value estimated at over $25 billion. There is thus great unmet need in the pharmacological treatment of pain around the world.
Arrowhead Conferences’ Pain Therapeutics Summit 2007 brings together leaders from the pharmaceutical community to discuss new avenues of research in the field of pain therapeutics and the latest advances in the field.
At this conference, hear from experts in the field regarding new targets for pain relief in the areas of neuropathic pain, nociceptive pain, chronic pain and inflammatory conditions. Moreover, special consideration will be given to the roles that drug delivery and specialty pharma will play in the future management of pain as well as the development of drug-abuse resistant products.
For information about our Pre-Conference Workshop, entitled Key Issues on the Critical Path in the Discovery of Medicines for Neuropathic Pain, CLICK HERE.
VPs, Managers, Heads, Directors and Associates from the areas of:
as well as individuals from
For more infomation about this conference, please contact us at 1-866-397-1376 or 1-312-244-3703 or email us at arrowheadconferences@arrowheadpublishers.com
To enquire about sponsorship and/or exhibiting at this conference please contact marketing@arrowheadpublishers.com